Director/PDMR Shareholding

Omega Diagnostics Group PLC

15 August 2023

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director/PDMR Shareholding

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that on 14 August 2023 it received notification that Jag Grewal, Chief Executive Officer, had purchased 296,009 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at a price of 2.70 pence each.

A summary of Mr Grewal's resultant holdings is below:

Director	Board Position	Existing number of Ordinary Shares	Ordinary Shares Purchased	Total beneficial holding of Ordinary Shares following this acquisition
				Number of Ordinary Shares	Approximate % of Company's issued share capital
Jag Grewal	CEO	2,164,830	296,009	2,460,839	1.03%

Contacts: 

Omega Diagnostics Group PLC			www.omegadx.com
Jag Grewal, Chief Executive Officer				via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd			Tel: [phone]
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Lianne Applegarth		Mob: [phone]
Sam Allen		Mob: [phone]

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 85 countries and is now focused on the health and nutrition sector.

www.omegadx.com

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jag Grewal
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group PLC
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 4 pence each ISIN: GB00B1VCP282
b)	Nature of the transaction	Ordinary Shares purchased
c)	Price(s) and volume(s)	Price(s) Volume(s) 2.70 pence 296,009
d)	Aggregated information -Aggregated volume - Price	See above
e)	Date of the transaction	14.08.2023
f)	Place of the transaction	London Stock Exchange

 

END